<DOC>
	<DOCNO>NCT02268786</DOCNO>
	<brief_summary>The purpose current study evaluate effect preimplantation genetic screening ( PGS ) next generation sequencing ( NGS ) compare standard morphological assessment embryos pregnancy rate randomize control trial ( RCT ) . All embryos vitrify single embryo transfer ( SET ) perform either screen unscreened embryo depend randomization .</brief_summary>
	<brief_title>Single Embryo TrAnsfeR Euploid Embryo</brief_title>
	<detailed_description />
	<mesh_term>Infertility</mesh_term>
	<mesh_term>Aneuploidy</mesh_term>
	<criteria>Patient undergo IVF At least 2 blastocyst suitable biopsy day 5 6 embryo development History two prior implantation failure follow IVF History one miscarriage viable pregnancy One partner know carrier ( ) chromosomal abnormality Known genetic carrier couple and/or one partner carrier know autosomal dominant disorder Any nonstudy related preimplantation genetic testing Use donor oocyte Use gestational carrier ( surrogate donor egg recipient ) . Severe oligospermia ( &lt; 1,000,000 sperm/ml ) ; Surgical Sperm Retrieval reason postvasectomy CAVD Low ovarian reserve ( FSH ) &gt; 10 IU/L day 24 prior menstrual cycle and/or ( AMH ) &lt; 7 pmol/L ( &lt; 1 ng/ml ) Gender selection cycle Concurrent participation another clinical trial</criteria>
	<gender>Female</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Preimplantation Genetic Screening</keyword>
	<keyword>Blastocyst</keyword>
	<keyword>Vitrification</keyword>
	<keyword>In vitro fertilization</keyword>
	<keyword>non-invasive prenatal testing</keyword>
	<keyword>next generation sequence</keyword>
</DOC>